Osimertinib, Targeted therapy, EGFR-TKI, Third generation, Unreversible inhibitor, Treats EGFR-mutated NSCLC, Ex19Del mutation, L858R mutation, Anti-CNS metastasis,
Sale!
Lucius
Replica of Osimertinib: EGFRm NSCLC Targeted Therapy
Original price was: $567.00.$408.00Current price is: $408.00.
Osimertinib, Targeted therapy, EGFR-TKI, Third generation, Unreversible inhibitor, Treats EGFR-mutated NSCLC, Ex19Del mutation, L858R mutation, Anti-CNS metastasis,